Jefferies Maintains Buy on Roivant Sciences, Raises Price Target to $52

Benzinga · 1d ago
Jefferies analyst Dennis Ding maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $42 to $52.